The vaccine, dubbed rVSV-ZEBOV, is not yet licensed, but displayed high levels of efficacy in previously reported clinical trials.
Details of the vaccination campaign have not yet been announced.
More articles on infection control:
Scientists reengineer vancomycin to fight superbug
Hot or cool: Water temperature does not impact bacteria removal during hand washing, study shows
Study: 5 risk factors for KPC-producing Enterobacteriaceae
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
